Madrid, Spain: Cannabis’ active components show promise in halting the progression of certain neurodegerative disorders and should be evaluated in clinical trials, according to a review published online in the British Journal of Pharmacology. An international...
New research in The Journal of Molecular Pharmacology demonstrates that Cannabis compounds may be a promising treatment for Alzheimer’s disease. It may seem counter-intuitive that compounds from the Cannabis plant may preserve memory, however Cannabidiol (CBD) and...
We should be very wary about the DEA allowing regulation and marketing of pharmaceutical products containing plant-derived THC. “[M]arijuana has no scientifically proven medical value.” So stated the United States Drug Enforcement Administration (DEA) on...
Alzheimer’s disease (AD) is characterized by enhanced -amyloid peptide (A) deposition along with glial activation in senile plaques, selective neuronal loss, and cognitive deficits. Cannabinoids are neuroprotective agents against excitotoxicity in vitro and...
ScienceDaily – Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe. Its use increased in almost all EU countries during the 1990s, in particular among young people, including...
The active ingredient in marijuana may stall decline from Alzheimer’s disease, research suggests. Scientists showed a synthetic version of the compound may reduce inflammation associated with Alzheimer’s and thus help to prevent mental decline. They hope...
